[Federal Register Volume 67, Number 119 (Thursday, June 20, 2002)]
[Notices]
[Pages 42003-42004]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-15496]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-02-62]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call the CDC Reports 
Clearance Officer on (404)498-1210.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Send comments to Anne O'Connor, CDC 
Assistant Reports Clearance Officer, 1600 Clifton Road, MS-D24, 
Atlanta, GA 30333. Written comments should be received within 60 days 
of this notice.
    Proposed Project: National Health Care Provider Survey on Genital 
Human Papillomavirus Infection--NEW--National Center for HIV, STD, and 
TB Prevention (NCHSTP), Centers for Disease Control and Prevention 
(CDC). CDC is proposing to conduct a national survey of health care 
providers' knowledge, attitudes, and practices in caring for patients 
at risk for or infected with genital human papillomavirus (HPV).
    Genital HPV infection is common among sexually active populations. 
An estimated 50 percent of sexually active adults have been infected 
with one or more genital HPV types, making this the most common 
sexually transmitted infection in the United States (Cates, 1999). Many 
health care providers may not be aware of data demonstrating the high 
prevalence of this sexually transmitted virus, the association of 
certain HPV types with various clinical manifestations including 
cervical and other anogenital cancers, or the type-specific natural 
history of HPV infection. To date, however, no nationally 
representative qualitative or quantitative surveys have measured health 
care providers' knowledge, attitudes, and practices about genital HPV 
infection.
    The CDC proposes to fill that gap through a national sample survey 
of clinicians in 13 specialties who care for substantial numbers of 
sexually active patients at risk for acquiring HPV, infected with 
genital HPV, or that have at least one of two clinical manifestations 
of HPV infection, cervical neoplasia or anogenital warts. The group of 
clinicians includes primary care clinicians, as well as selected 
specialists to whom patients with genital HPV infection, cervical 
neoplasia, or anogenital warts may be referred for HPV diagnosis, 
treatment, or management. These will include 11 physician specialties, 
pediatrics, obstetrics/gynecology, family and general practice, 
internal medicine, infectious disease, oncology, gynecologic oncology, 
dermatology, urology, colorectal surgery; and three mid-level provider 
specialties, nurse practitioners, certified nurse midwives, and 
physician assistants.
    The survey will be sent to 730 clinicians of each specialty, 
totaling 9,490 clinicians. An 80 percent response rate is anticipated, 
and 23 percent of these are expected to be ineligible for various 
reasons (e.g., retired, deceased, no patient care), resulting in a 
total of 5,850 completed surveys. The survey will provide baseline 
information on practicing clinicians' knowledge, attitudes and 
practices concerning patients at risk for or infected with HPV. The 
survey findings will be used to inform CDC initiatives and

[[Page 42004]]

recommendations for HPV control including appropriate practices for HPV 
testing, referral and clinical management, counseling, patient 
education, sex partner services, and clinician training and education 
in these areas. The information gathered from the survey will also 
provide a valuable knowledge base to guide the development and 
implementation of interventions to improve the prevention, control, and 
management of genital HPV infection in the U.S.
    Data collection will involve a mail survey of a stratified random 
sample of practicing clinicians in 13 specialties. A reminder postcard 
will follow the survey mailing after one week, a second mailing to non-
respondents at four weeks, a third mailing to non-respondents at seven 
weeks, and a final mailing to non-respondents at ten weeks. A study 
specific computerized tracking and reporting system will monitor all 
phases of survey mailings. Receipt of the completed survey or a refusal 
will be logged into this computerized tracking system to ensure that 
respondents who return the survey or decline participation will not be 
contacted with reminders. There are no costs to respondents.

----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden/
                   Respondents                       Number of      responses/     response (in    Total burden
                                                    respondents     respondent        hours)        (in hours)
----------------------------------------------------------------------------------------------------------------
Office Managers.................................            1742               1            2/60              58
Clinicians......................................            5850               1           20/60            1950
                                                 ---------------------------------------------------------------
    Total.......................................  ..............  ..............  ..............            2035
----------------------------------------------------------------------------------------------------------------


    Dated: June 13, 2002.
Nancy E. Cheal,
Acting Associate Director for Policy, Planning and Evaluation, Centers 
for Disease Control and Prevention.
[FR Doc. 02-15496 Filed 6-19-02; 8:45 am]
BILLING CODE 4163-18-P